Northwest Biotherapeutics Partners with SPIMACO to Advance DCVax-L in Saudi Arabia
BETHESDA, Md., August 6, 2026 Northwest Biotherapeutics announced that it has entered into a non-binding Memorandum of Understanding (MOU)...
MENA
Advertisement
Ocugen Signs OCU400 Licensing Agreement with Roots Pharma
MALVERN, Pa., July 13, 2026 Ocugen announced the signing of a binding term sheet with Roots Pharmaceutical and its...
AstraZeneca and Daiichi Sankyo Secure FDA Approval for Enhertu in Early HER2 Breast Cancer
WILMINGTON, Del., May 15, 2026 AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA)...
SERB and Hansa Biopharma Strengthen Rare Disease Portfolio With Idefirix Agreement
BRUSSELS, Belgium, May 19, 2026 SERB Pharmaceuticals and Hansa Biopharma have announced a strategic €115 million licensing agreement granting...
Advertisement
